Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-10229570-AAA for the Treatment of Acne Vulgaris
NCT01326780Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Mar 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-10229570 in acne vulgaris, sponsored by Valeant Pharmaceuticals. Started Mar 2011; status: completed.
02
Drugs
JNJ-10229570
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01326780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01326780.